Drugs News and Research

RSS

Probe to measure immune function could lead to determine nanoparticle-based drugs for cancer patients

The development of a probe to measure the body's immune function could lead to more accurate, individualized doses for cancer patients prescribed nanoparticle-based drugs, according to research conducted at the University of North Carolina.

21 Nov 2013

Researchers engineering first-ever living, three-dimensional human arrhythmic tissue

A foundational study published in top biomedical journal PNAS (Proceedings of the National Academy of Sciences) this week by researchers at the University of Toronto's Institute of Biomaterials & Biomedical Engineering and the McEwen Centre for Regenerative Medicine have identified the optimal structure and cell ratio associated with heart function - and the discovery has already led the team to another research first: the engineering of the first-ever living, three-dimensional human arrhythmic tissue.

21 Nov 2013

Buck Institute research provides method to study sarcopenia

Our epigenome is a set of chemical switches that turn parts of our genome off and on at strategic times and locations. These switches help alter the way our cells act and are impacted by environmental factors including diet, exercise and stress. Research at the Buck Institute reveals that aging also effects the epigenome in human skeletal muscle. The study, appearing on line in Aging Cell, provides a method to study sarcopenia, the degenerative loss of muscle mass that begins in middle age.

21 Nov 2013

Covagen, TRL expand research collaboration to generate bispecific FynomAb

Covagen and Tanabe Research Laboratories U.S.A, Inc., a fully owned subsidiary of Mitsubishi Tanabe Pharma Corporation, today announced that they expanded their strategic research collaboration. MTPC and TRL have nominated a first bispecific FynomAb for formal preclinical development which triggered an undisclosed milestone payment. MTPC and TRL also exercised an option for a second bispecific FynomAb program based on the parties' research and licensing agreement signed in October 2012.

21 Nov 2013

Henry Ford offers electric stimulation of brain using FDA-approved device for hard-to-treat epilepsy cases

Because of its participation in a pivotal trial, Henry Ford Hospital will be the first in Michigan to offer electric stimulation of the brain using a newly FDA-approved device for hard-to-treat epilepsy cases.

21 Nov 2013

Using radiation models to improve cancer therapies: an interview with Adrian Treverton, COO of Xstrahl and Jean-Pierre Wery, President of Crown Bioscience

What we are trying to do is take a cancer model like the PDX model (patient-derived tumor xenograft), which is a human-derived cancer growing in an in vivo model and apply radiation to that model.

From Xstrahl 20 Nov 2013

First Edition: November 20, 2013

Today's early morning highlights from the major news organizations, including reports that President Barack Obama places some of the blame for the health law's woes with Republicans, and details of comments by an Obama administration tech official that a large portion of the healthcare.gov 'back office' functions are yet to be built.

20 Nov 2013

Parkinson's Institute, Population Diagnostics discover new genes relevant to Parkinson's disease

The Parkinson's Institute and Clinical Center announced today that they, in partnership with Population Diagnostics, Inc., have discovered a number of new genes relevant to the cause of Parkinson's disease.

20 Nov 2013

DNA-damaging drug and MK2 inhibitor combination could be effective against cancer

About half of all cancer patients have a mutation in a gene called p53, which allows tumors to survive and continue growing even after chemotherapy severely damages their DNA.

20 Nov 2013

Rapid DNA biochip tests for screening disease-causing bacteria

Patients affected by a bacterial infection can usually be treated with an antibiotic. But sometimes a resistant bacterial strain is causing the infection. In a hospital setting, doctors ideally want to know if they are dealing with such bacteria and which drugs they should choose. But if the doctor runs a test it can take days to get a result. Now, a European project is paving the way for much more rapid tests using DNA biochips. The aim is to rapidly screen disease-causing bacteria using a microarray to spot which resistant genes are present in bacteria.

20 Nov 2013

Study compares prevalence, impact of chronic pain amongst different ethnic groups in Tower Hamlets

A new study in the London Borough of Tower Hamlets, funded by medical research charity Arthritis Research UK, may help improve GPs’ understanding of chronic musculoskeletal pain amongst different ethnic groups and develop better strategies for self-management as a result

20 Nov 2013

Vect-Horus, AAA form scientific collaboration to open new avenues in treatment of brain diseases

Vect-Horus, a French company specialized in the development of vector molecules for the central nervous system, announces today it has signed a scientific collaboration agreement with Advanced Accelerator Applications, a fast growing international player in Molecular Nuclear Medicine. The financial terms of the deal have not been disclosed.

20 Nov 2013

First look at The Endocrine Society's Performance-Enhancing Drugs Scientific Statement

Performance-enhancing drugs are synonymous with the names of elite athletes including Alex Rodriguez and Ryan Braun. In reality, major league athletes make up only a fraction of the nation's 3 million performance-enhancing drug users. As thousands of PED users age into their 50s, the long-term health effects are expected to become visible for the first time.

20 Nov 2013

Senate gives final approval to bill tightening control over drug-compounding pharmacies

The Senate gave final approval to a bill Monday that gives federal regulators greater oversight of compounding pharmacies like the ones responsible for a deadly meningitis outbreak last year. The President is expected to sign the bill.

20 Nov 2013

New approach may help researchers find new drugs for human diseases

A team of biochemists and mathematicians have developed a sophisticated geometric model to predict how a biological molecule will interact with water molecules, computing the results up to 20 times faster than other existing approaches. This new approach may help researchers find new drugs to treat human diseases, said the team, who described their theoretical approach in the Journal of Chemical Physics, which is produced by AIP Publishing.

20 Nov 2013

Gene-based method for selecting doses of warfarin no better than standardized dosing methods

A new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania has determined that a gene-based method for selecting patients' doses of the popular heart medication warfarin is no better than standardized dosing methods. The study was presented today at the 2013 Scientific Sessions of the American Heart Association and published simultaneously in the New England Journal of Medicine.

20 Nov 2013

Viewpoints: GOP excuse for 'doing nothing;' Sen. Rubio: No taxpayer-funded bailout of the insurance industry

As the people's representatives, the U.S. Congress should completely eliminate the possibility of a bailout of insurance companies. On Tuesday I am introducing legislation that would eliminate the risk corridor provision, ensuring that no taxpayer-funded bailout of the health insurance industry will ever occur under ObamaCare. If this disaster of a law cannot survive without a bailout rescue valve, it is yet another reason why it should be repealed (Sen. Marco Rubio, R-Fla., 11/18).

20 Nov 2013

Drugs News and Research

Probe to measure immune function could lead to determine nanoparticle-based drugs for cancer patients

Researchers engineering first-ever living, three-dimensional human arrhythmic tissue

Buck Institute research provides method to study sarcopenia

Covagen, TRL expand research collaboration to generate bispecific FynomAb

Henry Ford offers electric stimulation of brain using FDA-approved device for hard-to-treat epilepsy cases

Using radiation models to improve cancer therapies: an interview with Adrian Treverton, COO of Xstrahl and Jean-Pierre Wery, President of Crown Bioscience

First Edition: November 20, 2013

Parkinson's Institute, Population Diagnostics discover new genes relevant to Parkinson's disease

DNA-damaging drug and MK2 inhibitor combination could be effective against cancer

Rapid DNA biochip tests for screening disease-causing bacteria

Study compares prevalence, impact of chronic pain amongst different ethnic groups in Tower Hamlets

Vect-Horus, AAA form scientific collaboration to open new avenues in treatment of brain diseases

First look at The Endocrine Society's Performance-Enhancing Drugs Scientific Statement

Senate gives final approval to bill tightening control over drug-compounding pharmacies

New approach may help researchers find new drugs for human diseases

Gene-based method for selecting doses of warfarin no better than standardized dosing methods

Viewpoints: GOP excuse for 'doing nothing;' Sen. Rubio: No taxpayer-funded bailout of the insurance industry

Tasquinimod drug effective for men with metastatic castration-resistant prostate cancer

Patients at highest risk for suffering full-blown ischemic attack less likely to receive optimal care

Researchers use computer modeling to investigate complex relationships between spread and evolution of HIV virus

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News